Tag: J&J MedTech
J&J’s dual-energy ablation catheter deemed safe and effective in first-in-human SmartfIRE...
Johnson & Johnson (J&J) MedTech has today announced 12-month results from the SmartfIRE study, delivered as a late-breaking presentation at the ongoing European Heart...
J&J to resume Varipulse cases following ‘voluntary pause’ of US external...
Following a temporary, voluntary pause of US external evaluation and all US cases with its Varipulse catheter, Johnson & Johnson (J&J) is set to...
Cardiac Rhythm News’ top stories of 2024
From first-time clinical data to major industry debuts, here are Cardiac Rhythm News’ 10 most popular stories of 2024.
1. Abbott joins the pulsed field...
Johnson & Johnson MedTech wins CE mark approval for dual energy...
Johnson & Johnson MedTech has announced European CE mark approval of the Dual Energy Thermocool Smarttouch SF catheter for the treatment of cardiac arrhythmias.
The...
J&J MedTech receives US FDA approval for Varipulse PFA platform in...
Johnson & Johnson (J&J) MedTech has announced the US Food and Drug Administration (FDA) approval of the Varipulse pulsed field ablation (PFA) platform for...